Top

Published in:

Open Access 15-07-2023 | Cholecystectomy | Review

Evidence-based clinical practice guidelines for cholelithiasis 2021

Authors: Naotaka Fujita, Ichiro Yasuda, Itaru Endo, Hiroyuki Isayama, Takuji Iwashita, Toshiharu Ueki, Kenichiro Uemura, Akiko Umezawa, Akio Katanuma, Yu Katayose, Yutaka Suzuki, Junichi Shoda, Toshio Tsuyuguchi, Toshifumi Wakai, Kazuo Inui, Michiaki Unno, Yoshifumi Takeyama, Takao Itoi, Kazuhiko Koike, Satoshi Mochida

Published in: Journal of Gastroenterology | Issue 9/2023

Abstract

The Japanese Society of Gastroenterology first published evidence-based clinical practice guidelines for cholelithiasis in 2010, followed by a revision in 2016. Currently, the revised third edition was published to reflect recent evidence on the diagnosis, treatment, and prognosis of cholelithiasis conforming to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Following this revision, the present English version of the guidelines was updated and published herein. The clinical questions (CQ) in the previous version were reviewed and rearranged into three newly divided categories: background questions (BQ) dealing with basic background knowledge, CQ, and future research questions (FRQ), which refer to issues that require further accumulation of evidence. Finally, 52 questions (29 BQs, 19 CQs, and 4 FRQs) were adopted to cover the epidemiology, pathogenesis, diagnosis, treatment, complications, and prognosis. Based on a literature search using MEDLINE, Cochrane Library, and Igaku Chuo Zasshi databases for the period between 1983 and August 2019, along with a manual search of new information reported over the past 5 years, the level of evidence was evaluated for each CQ. The strengths of recommendations were determined using the Delphi method by the committee members considering the body of evidence, including benefits and harms, patient preference, and cost–benefit balance. A comprehensive flowchart was prepared for the diagnosis and treatment of gallbladder stones, common bile duct stones, and intrahepatic stones, respectively. The current revised guidelines are expected to be of great assistance to gastroenterologists and general physicians in making decisions on contemporary clinical management for cholelithiasis patients.

Available only for authorised users

Tazuma S, Unno M, Igarashi Y, et al. Evidence-based clinical practice guidelines for cholelithiasis 2016. J Gastroenterol. 2017;52:276–300.PubMedCrossRef

Minds Manual Developing Committee. Minds Manual for Guideline Development 2017. Tokyo: Japan Council for Quality Health Care; 2017. (in Japanese)

Qaseem A, Kansagara D, Lin JS, et al. The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians: Update of Methods. Ann Intern Med. 2019;170:863–70.PubMedCrossRef

Yoshida M, Kinoshita Y, Watanabe M, et al. JSGE Clinical Practice Guidelines 2014: standards, methods, and process of developing the guidelines. J Gastroenterol. 2015;50:4–10.PubMedCrossRef

Health Statistics Association of Japan. Estimated number of patients based on patient surveys. Index of Health. 1993;39:29–35 (in Japanese).

Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.PubMedCrossRef

Kameda H, Kozuki T, Tanimura H, et al. Report of cholelithiasis investigation committee of the Japan Biliary Association. J Jpn Biliary Assoc. 1990;4:396–404 (in Japanese with English abstract).

Tanimura H, Uchiyama K. Report on the results of the national survey on cholelithiasis 1996. J Jpn Biliary Assoc. 1997;11:133–140 (in Japanese with English abstract)

The Japanese Biliary Society Cholelithiasis Survey Project. National cholelithiasis survey report 1997. J Jpn Biliary Assoc. 1997;1998(12):276–93 (in Japanese).

10.

Committee JBA. Report on the 2013 National Survey for biliary stone. J Jpn Biliary Assoc. 2014;28:612–7 (in Japanese).

11.

Suzuki Y, Mori T, Yokoyama M, et al. Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years. J Hepatobiliary Pancreat Sci. 2014;21:617–22.PubMedCrossRef

12.

Hay DW, Carey MC. Pathophysiology and pathogenesis of cholesterol gallstone formation. Semin Liver Dis. 1990;10:159–70.PubMedCrossRef

13.

Shoda J. Classification and pathogenesis of gallstones. J Jpn Biliary Assoc. 2013;27:672–679 (in Japanese with English abstract)

14.

Ko CW, Sekijima JH, Lee SP. Biliary sludge. Ann Intern Med. 1999;130:301–11.PubMedCrossRef

15.

Jonkers IJ, Smelt AH, Ledeboer M, et al. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut. 2003;52:109–15.PubMedPubMedCentralCrossRef

16.

Carey MC. Pathogenesis of gallstones. Am J Surg. 1993;165:410–9.PubMedCrossRef

17.

Vitek L, Carey MC. New pathophysiological concepts underlying pathogenesis of pigment gallstones. Clin Res Hepatol Gastroenterol. 2012;36:122–9.PubMedCrossRef

18.

Ise H, Moriyasu A, Suzuki N, et al. Pathogenesis of black stones. J Hepatobiliary Pancreat Surg. 1997;4:412–6.CrossRef

19.

Vitek L, Carey MC. Enterohepatic cycling of bilirubin as a cause of “black” pigment gallstones in adult life. Eur J Clin Invest. 2003;33:799–810.PubMedCrossRef

20.

Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep. 2005;7:132–40.PubMedCrossRef

21.

Stampfer MJ, Maclure KM, Colditz GA, et al. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55:652–8.PubMedCrossRef

22.

Halpern Z, Rubin M, Harach G, et al. Bile and plasma lipid composition in non-obese normolipidemic subjects with and without cholesterol gallstones. Liver. 1993;13:246–52.PubMedCrossRef

23.

Kim HS, Cho SK, Kim CS, et al. Big data and analysis of risk factors for gallbladder disease in the young generation of Korea. PLoS ONE. 2019;14: e0211480.PubMedPubMedCentralCrossRef

24.

Méndez-Sánchez N, Zamora-Valdés D, Chávez-Tapia NC, et al. Role of diet in cholesterol gallstone formation. Clin Chim Acta. 2007;376:1–8.PubMedCrossRef

25.

Cuevas A, Miquel JF, Reyes MS, et al. Diet as a risk factor for cholesterol gallstone disease. J Am Coll Nutr. 2004;23:187–96.PubMedCrossRef

26.

Barbara L, Sama C, Labate AMM, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology. 1987;7:913–7.PubMedCrossRef

27.

Grodstein F, Colditz GA, Hunter DJ, et al. A prospective study of symptomatic gallstones in women: relation with oral contraceptives and other risk factors. Obstet Gynecol. 1994;84:207–14.PubMed

28.

Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med. 1993;119:1029–35.PubMedCrossRef

29.

Ohya T, Tazuma S. Pathogenesis of Gallstone and Pancreatic Stone Formation. Endoscopia Digestiva. 2019;31:1594–1600 (in Japanese with English abstract).

30.

Tsai C-J, Leitzmann MF, Willett WC, et al. Macronutrients and insulin resistance in cholesterol gallstone disease. Off J Am Coll Gastroenterol ACG. 2008;103:2932–9.CrossRef

31.

Thomas LA, Veysey MJ, Bathgate T, et al. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis. Gastroenterology. 2000;119:806–15.PubMedCrossRef

32.

Colecchia A, Mazzella G, Sandri L, et al. Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients. World J Gastroenterol. 2006;12:5336.PubMedPubMedCentralCrossRef

33.

Gustafsson U, Benthin L, Granström L, et al. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. Hepatology. 2005;41:1322–8.PubMedCrossRef

34.

Asai Y, Yamada T, Tsukita S, et al. Activation of the hypoxia inducible factor 1α subunit pathway in steatotic liver contributes to formation of cholesterol gallstones. Gastroenterology. 2017;152(1521–1535): e8.

35.

Pomeranz IS, Shaffer EA. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology. 1985;88:787–91.PubMedCrossRef

36.

Pauletzki J, Althaus R, Holl J, et al. Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. Gastroenterology. 1996;111:765–71.PubMedCrossRef

37.

Portincasa P, Di Ciaula A, Wang HH, et al. Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology. 2008;47:2112–26.PubMedCrossRef

38.

Inoue K, Fuchigami A, Higashide S, et al. Gallbladder sludge and stone formation in relation to contractile function after gastrectomy. A prospective study. Ann Surg. 1992;215:19.PubMedPubMedCentralCrossRef

39.

Shoda J, He B-F, Tanaka N, et al. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. Hepatology. 1995;21:1291–302.PubMed

40.

Tsai C-J, Leitzmann MF, Hu FB, et al. A prospective cohort study of nut consumption and the risk of gallstone disease in men. Am J Epidemiol. 2004;160:961–8.PubMedCrossRef

41.

Leitzmann MF, Stampfer MJ, Willett WC, et al. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology. 2002;123:1823–30.PubMedCrossRef

42.

Festi D, Colecchia A, Orsini M, et al. Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). Int J Obes. 1998;22:592–600.CrossRef

43.

Cha BH, Jang M-j, Lee SH. Alcohol consumption can reduce the risk of gallstone disease: a systematic review with a dose-response meta-analysis of case-control and cohort studies. Gut Liver. 2019;13:114.PubMedPubMedCentralCrossRef

44.

Leitzmann MF, Rimm EB, Willett WC, et al. Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med. 1999;341:777–84.PubMedCrossRef

45.

Shoda J, Miyamoto J, Kano M, et al. Simultaneous determination of plasma mevalonate and 7 α-hydroxy-4-cholesten-3-one levels in hyperlipoproteinemia: Convenient indices for estimating hepatic defects of cholesterol and bile acid syntheses and biliary cholesterol supersaturation. Hepatology. 1997;25:18–26.PubMed

46.

Tsai CJ, Leitzmann MF, Willett WC, et al. Statin use and the risk of cholecystectomy in women. Gastroenterology. 2009;136:1593–600.PubMedCrossRef

47.

Festi D, Frabboni R, Bazzoli F, et al. Gallbladder motility in cholesterol gallstone disease: effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology. 1990;99:1779–85.PubMedCrossRef

48.

Veysey M, Malcolm P, Mallet A, et al. Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial. Gut. 2001;49:828–34.PubMedPubMedCentralCrossRef

49.

Shoda J. Natural History of Gallstones. J Jpn Biliary Assoc. 2017;31:187–195 (in Japanese with English abstract)

50.

Festi D, Reggiani MLB, Attili AF, et al. Natural history of gallstone disease: expectant management or active treatment? Results from a population-based cohort study. J Gastroenterol Hepatol. 2010;25:719–24.PubMedCrossRef

51.

Shabanzadeh DM, Sorensen LT, Jorgensen T. A Prediction Rule for Risk Stratification of Incidentally Discovered Gallstones: Results From a Large Cohort Study. Gastroenterology. 2016;150(156–167): e1.

52.

Persson GE. Expectant management of patients with gallbladder stones diagnosed at planned investigation. A prospective 5- to 7-year follow-up study of 153 patients. Scand J Gastroenterol. 1996;31:191–9.PubMedCrossRef

53.

Dworken HJ. Recent experiences with spontaneously disappearing gallstones. Gastroenterology. 1960;38:76–86.PubMedCrossRef

54.

Norman CH Jr, Butera DG. Spontaneously disappearing gallstones. J Natl Med Assoc. 1979;71:61.PubMedPubMedCentral

55.

Friedman GD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg. 1993;165:399–404.PubMedCrossRef

56.

Thistle JL, Cleary PA, Lachin JM, et al. The natural history of cholelithiasis: the National Cooperative Gallstone Study. Ann Intern Med. 1984;101:171–5.PubMedCrossRef

57.

Lamberts MP, Ozdemir C, Drenth JPH, et al. Cost-effectiveness of a new strategy to identify uncomplicated gallstone disease patients that will benefit from a cholecystectomy. Surg Endosc. 2017;31:2534–40.PubMedCrossRef

58.

Brazzelli M, Cruickshank M, Kilonzo M, et al. Systematic review of the clinical and cost effectiveness of cholecystectomy versus observation/conservative management for uncomplicated symptomatic gallstones or cholecystitis. Surg Endosc. 2015;29:637–47.PubMedCrossRef

59.

Schmidt M, Sondenaa K, Vetrhus M, et al. A randomized controlled study of uncomplicated gallstone disease with a 14-year follow-up showed that operation was the preferred treatment. Dig Surg. 2011;28:270–6.PubMedCrossRef

60.

Cariati A, Piromalli E, Cetta F. Gallbladder cancers: associated conditions, histological types, prognosis, and prevention. Eur J Gastroenterol Hepatol. 2014;26:562–9.PubMedCrossRef

61.

Diehl AK. Gallstone size and the risk of gallbladder cancer. JAMA. 1983;250:2323–6.PubMedCrossRef

62.

Lowenfels AB, Lindstrom CG, Conway MJ, et al. Gallstones and risk of gallbladder cancer. J Natl Cancer Inst. 1985;75:77–80.PubMed

63.

Nervi F, Duarte I, Gomez G, et al. Frequency of gallbladder cancer in Chile, a high-risk area. Int J Cancer. 1988;41:657–60.PubMedCrossRef

64.

WHO. Combined oral contraceptives and gallbladder cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Epidemiol. 1989;18:309–14.

65.

Kato K, Akai S, Tominaga S, et al. A case-control study of biliary tract cancer in Niigata Prefecture. Japan Jpn J Cancer Res. 1989;80:932–8.PubMed

66.

Kimura W, Shimada H, Kuroda A, et al. Carcinoma of the gallbladder and extrahepatic bile duct in autopsy cases of the aged, with special reference to its relationship to gallstones. Am J Gastroenterol. 1989;84:386–90.PubMed

67.

Zatonski WA, Lowenfels AB, Boyle P, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst. 1997;89:1132–8.PubMedCrossRef

68.

Okamoto M, Okamoto H, Kitahara F, et al. Ultrasonographic evidence of association of polyps and stones with gallbladder cancer. Am J Gastroenterol. 1999;94:446–50.PubMedCrossRef

69.

Khan ZR, Neugut AI, Ahsan H, et al. Risk factors for biliary tract cancers. Am J Gastroenterol. 1999;94:149–52.PubMedCrossRef

70.

Scott TE, Carroll M, Cogliano FD, et al. A case-control assessment of risk factors for gallbladder carcinoma. Dig Dis Sci. 1999;44:1619–25.PubMedCrossRef

71.

Csendes A, Becerra M, Rojas J, et al. Number and size of stones in patients with asymptomatic and symptomatic gallstones and gallbladder carcinoma: a prospective study of 592 cases. J Gastrointest Surg. 2000;4:481–5.PubMedCrossRef

72.

Serra I, Yamamoto M, Calvo A, et al. Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer. 2002;102:407–11.PubMedCrossRef

73.

Roa I, Ibacache G, Roa J, et al. Gallstones and gallbladder cancer-volume and weight of gallstones are associated with gallbladder cancer: a case-control study. J Surg Oncol. 2006;93:624–8.PubMedCrossRef

74.

Ahrens W, Timmer A, Vyberg M, et al. Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study. Eur J Gastroenterol Hepatol. 2007;19:623–30.PubMedCrossRef

75.

Grainge MJ, West J, Solaymani-Dodaran M, et al. The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer. 2009;100:178–80.PubMedCrossRef

76.

Alvi AR, Siddiqui NA, Zafar H. Risk factors of gallbladder cancer in Karachi-a case-control study. World J Surg Oncol. 2011;9:164.PubMedPubMedCentralCrossRef

77.

Maringhini A, Moreau JA, Melton LJ 3rd, et al. Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. Ann Intern Med. 1987;107:30–5.PubMedCrossRef

78.

Chow WH, Johansen C, Gridley G, et al. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer. 1999;79:640–4.PubMedPubMedCentralCrossRef

79.

Ishiguro S, Inoue M, Kurahashi N, et al. Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification. Cancer Causes Control. 2008;19:33–41.PubMedCrossRef

80.

Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591–602.PubMedCrossRef

81.

Yagyu K, Lin Y, Obata Y, et al. Bowel movement frequency, medical history and the risk of gallbladder cancer death: a cohort study in Japan. Cancer Sci. 2004;95:674–8.PubMedCrossRef

82.

Schnelldorfer T. Porcelain gallbladder: a benign process or concern for malignancy? J Gastrointest Surg. 2013;17:1161–8.PubMedCrossRef

83.

Nomura Y, Inui K, Yoshino J, et al. Causes of cholelithiasis, epidemiology, gallbladder stones and gallbladder cancer. Naika. 2005;95:223–6 (in Japanese).

84.

Otani K, Chijiiwa K, Ouchida J, et al. Indications for resection of cholelithiasis and gallbladder polyps. Surgery. 2009;71:29–33.

85.

Horiguchi Y, Sakamoto K, Harada M, et al. Treatment of cholelithiasis: The natural history and treatment strategy for asymptomatic gallbladder stones. Naika. 2005;95:251–4 (in Japanese).

86.

Koga A, Ichimiya H, Yamaguchi K, et al. Hepatolithiasis associated with cholangiocarcinoma. Possible etiologic significance Cancer. 1985;55:2826–9.PubMed

87.

Chen MF, Jan YY, Wang CS, et al. A reappraisal of cholangiocarcinoma in patient with hepatolithiasis. Cancer. 1993;71:2461–5.PubMedCrossRef

88.

Sheen-Chen SM, Chou FF, Eng HL. Intrahepatic cholangiocarcinoma in hepatolithiasis: a frequently overlooked disease. J Surg Oncol. 1991;47:131–5.PubMedCrossRef

89.

Kawarada Y, Mita T. Cholangiocarcinoma associated with hepatolithiasis. Tan to Sui. 1994;15:435–46 (in Japanese).

90.

Chijiiwa K, Yamashita H, Yoshida J, et al. Current management and long-term prognosis of hepatolithiasis. Arch Surg. 1995;130:194–7.PubMedCrossRef

91.

Kubo S, Kinoshita H, Hirohashi K, et al. Hepatolithiasis associated with cholangiocarcinoma. World J Surg. 1995;19:637–41.PubMedCrossRef

92.

Liu CL, Fan ST, Wong J. Primary biliary stones: diagnosis and management. World J Surg. 1998;22:1162–6.PubMedCrossRef

93.

Chen DW, Tung-Ping Poon R, Liu CL, et al. Immediate and long-term outcomes of hepatectomy for hepatolithiasis. Surgery. 2004;135:386–93.PubMedCrossRef

94.

Cheung MT, Kwok PC. Liver resection for intrahepatic stones. Arch Surg. 2005;140:993–7.PubMedCrossRef

95.

Vetrone G, Ercolani G, Grazi GL, et al. Surgical therapy for hepatolithiasis: a Western experience. J Am Coll Surg. 2006;202:306–12.PubMedCrossRef

96.

Lee TY, Chen YL, Chang HC, et al. Outcomes of hepatectomy for hepatolithiasis. World J Surg. 2007;31:479–82.PubMedCrossRef

97.

Al-Sukhni W, Gallinger S, Pratzer A, et al. Recurrent pyogenic cholangitis with hepatolithiasis–the role of surgical therapy in North America. J Gastrointest Surg. 2008;12:496–503.PubMedCrossRef

98.

Cheon YK, Cho YD, Moon JH, et al. Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis. Surgery. 2009;146:843–53.PubMedCrossRef

99.

Uenishi T, Hamba H, Takemura S, et al. Outcomes of hepatic resection for hepatolithiasis. Am J Surg. 2009;198:199–202.PubMedCrossRef

100.

Tabrizian P, Jibara G, Shrager B, et al. Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg. 2012;215:622–6.PubMedCrossRef

101.

Suzuki Y, Mori T, Abe N, et al. Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese Multicenter study. Hepatol Res. 2012;42:166–70.PubMedCrossRef

102.

Guglielmi A, Ruzzenente A, Valdegamberi A, et al. Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients. Eur J Surg Oncol. 2014;40:567–75.PubMedCrossRef

103.

Zhu QD, Zhou MT, Zhou QQ, et al. Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma. World J Surg. 2014;38:2097–104.PubMedCrossRef

104.

Furukawa M, Sasaki M, Ohtsubo M, et al. Natural history of primary hepatolithiasis. Tan to Sui. 1998;19:1021–7 (in Japanese).

105.

Jo JH, Chung MJ, Park JY, et al. High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study. Surg Endosc. 2013;27:4210–6.PubMedCrossRef

106.

Liu ZY, Zhou YM, Shi LH, et al. Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study. Hepatobiliary Pancreat Dis Int. 2011;10:626–31.PubMedCrossRef

107.

Suzuki Y, Mori T, Yokoyama M, et al. Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese Multicenter study Journal of Japan Biliary Association. 2013;27:700–704 (in Japanese with English abstract)

108.

Chijiiwa K, Ichimiya H, Kuroki S, et al. Late development of cholangiocarcinoma after the treatment of hepatolithiasis. Surg Gynecol Obstet. 1993;177:279–82.PubMed

109.

Jan YY, Chen MF, Wang CS, et al. Surgical treatment of hepatolithiasis: long-term results. Surgery. 1996;120:509–14.PubMedCrossRef

110.

Huang MH, Chen CH, Yang JC, et al. Long-term outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis. Am J Gastroenterol. 2003;98:2655–62.PubMedCrossRef

111.

Li SQ, Liang LJ, Peng BG, et al. Outcomes of liver resection for intrahepatic stones: a comparative study of unilateral versus bilateral disease. Ann Surg. 2012;255:946–53.PubMedCrossRef

112.

Lin CC, Lin PY, Chen YL. Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: clinical implications. World J Gastroenterol. 2013;19:375–80.PubMedPubMedCentralCrossRef

113.

Tsuyuguchi T, Miyakawa K, Sugiyama H, et al. Ten-year long-term results after non-surgical management of hepatolithiasis, including cases with choledochoenterostomy. J Hepatobiliary Pancreat Sci. 2014;21:795–800.PubMedCrossRef

114.

Kim HJ, Kim JS, Suh SJ, et al. Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients. World J Surg. 2015;39:1537–42.PubMedCrossRef

115.

Meng ZW, Han SH, Zhu JH, et al. Risk Factors for Cholangiocarcinoma After Initial Hepatectomy for Intrahepatic Stones. World J Surg. 2017;41:835–43.PubMedCrossRef

116.

Kim HJ, Kang TU, Swan H, et al. Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones. Dig Dis Sci. 2018;63:3465–73.PubMedCrossRef

117.

Gibney EJ. Asymptomatic gallstones. Br J Surg. 1990;77:368–72.PubMedCrossRef

118.

Portincasa P, Moschetta A, Petruzzelli M, et al. Gallstone disease: symptoms and diagnosis of gallbladder stones. Best Pract Res Clin Gastroenterol. 2006;20:1017–29.PubMedCrossRef

119.

Tomida S, Abei M, Yamaguchi T, et al. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Hepatology. 1999;30:6–13.PubMedCrossRef

120.

Tazuma S, Kanno K, Kubota K, et al. Report on the 2013 national cholelithiasis survey in Japan. J Hepatobiliary Pancreat Sci. 2015;22:392–5.PubMedCrossRef

121.

Peng WK, Sheikh Z, Paterson-Brown S, et al. Role of liver function tests in predicting common bile duct stones in acute calculous cholecystitis. Br J Surg. 2005;92:1241–7.PubMedCrossRef

122.

Barakos JA, Ralls PW, Lapin SA, et al. Cholelithiasis: evaluation with CT. Radiology. 1987;162:415–8.PubMedCrossRef

123.

Neitlich T, Neitlich J. The imaging evaluation of cholelithiasis in the obese patient-ultrasound vs CT cholecystography: our experience with the bariatric surgery population. Obes Surg. 2009;19:207–10.PubMedCrossRef

124.

Ito K, Fujita N, Noda Y, et al. [The significance of magnetic resonance cholangiopancreatography in acute cholecystitis]. Nihon Shokakibyo Gakkai Zasshi. 2000;97:1472–9 (in Japanese with English abstract)

125.

Dahan P, Andant C, Levy P, et al. Prospective evaluation of endoscopic ultrasonography and microscopic examination of duodenal bile in the diagnosis of cholecystolithiasis in 45 patients with normal conventional ultrasonography. Gut. 1996;38:277–81.PubMedPubMedCentralCrossRef

126.

Yokoe M, Takada T, Strasberg SM, et al. New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012;19:578–85.PubMedPubMedCentralCrossRef

127.

Naidu K, Beenen E, Gananadha S, et al. The yield of fever, inflammatory markers and ultrasound in the diagnosis of acute cholecystitis: a validation of the 2013 Tokyo guidelines. World J Surg. 2016;40:2892–7.PubMedCrossRef

128.

Yokoe M, Takada T, Hwang TL, et al. Descriptive review of acute cholecystitis: Japan-Taiwan collaborative epidemiological study. J Hepatobiliary Pancreat Sci. 2017;24:319–28.PubMedCrossRef

129.

Gruber PJ, Silverman RA, Gottesfeld S, et al. Presence of fever and leukocytosis in acute cholecystitis. Ann Emerg Med. 1996;28:273–7.PubMedCrossRef

130.

Strasberg SM. Clinical practice. Acute calculous cholecystitis. N Engl J Med. 2008;358:2804–11.PubMedCrossRef

131.

Yokoe M, Takada T, Strasberg SM, et al. TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2013;20:35–46.PubMedCrossRef

132.

Hammarstrom L, Ranstam J. Factors predictive of bile duct stones in patients with acute calculous cholecystitis. Dig Surg. 1998;15:323–7.PubMedCrossRef

133.

Yarmish GM, Smith MP, Rosen MP, et al. ACR appropriateness criteria right upper quadrant pain. J Am Coll Radiol. 2014;11:316–22.PubMedPubMedCentralCrossRef

134.

Pinto A, Reginelli A, Cagini L, et al. Accuracy of ultrasonography in the diagnosis of acute calculous cholecystitis: review of the literature. Crit Ultrasound J. 2013;5(Suppl 1):S11.PubMedPubMedCentralCrossRef

135.

Ralls PW, Colletti PM, Lapin SA, et al. Real-time sonography in suspected acute cholecystitis. Prospective evaluation of primary and secondary signs. Radiology. 1985;155:767–71.PubMedCrossRef

136.

Martinez A, Bona X, Velasco M, et al. Diagnostic accuracy of ultrasound in acute cholecystitis. Gastrointest Radiol. 1986;11:334–8.PubMedCrossRef

137.

Cohan RH, Mahony BS, Bowie JD, et al. Striated intramural gallbladder lucencies on US studies: predictors of acute cholecystitis. Radiology. 1987;164:31–5.PubMedCrossRef

138.

Ralls PW, Halls J, Lapin SA, et al. Prospective evaluation of the sonographic Murphy sign in suspected acute cholecystitis. J Clin Ultrasound. 1982;10:113–5.PubMedCrossRef

139.

Bree RL. Further observations on the usefulness of the sonographic Murphy sign in the evaluation of suspected acute cholecystitis. J Clin Ultrasound. 1995;23:169–72.PubMedCrossRef

140.

Harvey RT, Miller WT Jr. Acute biliary disease: initial CT and follow-up US versus initial US and follow-up CT. Radiology. 1999;213:831–6.PubMedCrossRef

141.

Mirvis SE, Vainright JR, Nelson AW, et al. The diagnosis of acute acalculous cholecystitis: a comparison of sonography, scintigraphy, and CT. AJR Am J Roentgenol. 1986;147:1171–5.PubMedCrossRef

142.

Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25:17–30.PubMedCrossRef

143.

Kiriyama S, Takada T, Strasberg SM, et al. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012;19:548–56.PubMedPubMedCentralCrossRef

144.

Abboud PA, Malet PF, Berlin JA, et al. Predictors of common bile duct stones prior to cholecystectomy: a meta-analysis. Gastrointest Endosc. 1996;44:450–5.PubMedCrossRef

145.

Inui K, Fujita N. Diagnosis of choledocholithiasis. J Jpn Biliary Assoc. 2010;24:239–244 (in Japanese with English abstract)

146.

Tseng CW, Chen CC, Chen TS, et al. Can computed tomography with coronal reconstruction improve the diagnosis of choledocholithiasis? J Gastroenterol Hepatol. 2008;23:1586–9.PubMedCrossRef

147.

Mark DH, Flamm CR, Aronson N. Evidence-based assessment of diagnostic modalities for common bile duct stones. Gastrointest Endosc. 2002;56:S190–4.PubMedCrossRef

148.

Chen W, Mo JJ, Lin L, et al. Diagnostic value of magnetic resonance cholangiopancreatography in choledocholithiasis. World J Gastroenterol. 2015;21:3351–60.PubMedPubMedCentralCrossRef

149.

Jendresen MB, Thorboll JE, Adamsen S, et al. Preoperative routine magnetic resonance cholangiopancreatography before laparoscopic cholecystectomy: a prospective study. Eur J Surg. 2002;168:690–4.PubMedCrossRef

150.

Tse F, Liu L, Barkun AN, et al. EUS: a meta-analysis of test performance in suspected choledocholithiasis. Gastrointest Endosc. 2008;67:235–44.PubMedCrossRef

151.

Gurusamy KS, Giljaca V, Takwoingi Y, et al. Endoscopic retrograde cholangiopancreatography versus intraoperative cholangiography for diagnosis of common bile duct stones. Cochrane Database Syst Rev. 2015;(2):CD011548.

152.

Endo T, Ito K, Fujita N, et al. Intraductal ultrasonography in the diagnosis of bile duct stones: when and whom? Dig Endosc. 2011;23:173–5.PubMedCrossRef

153.

Kim DC, Moon JH, Choi HJ, et al. Usefulness of intraductal ultrasonography in icteric patients with highly suspected choledocholithiasis showing normal endoscopic retrograde cholangiopancreatography. Dig Dis Sci. 2014;59:1902–8.PubMedCrossRef

154.

Meeralam Y, Al-Shammari K, Yaghoobi M. Diagnostic accuracy of EUS compared with MRCP in detecting choledocholithiasis: a meta-analysis of diagnostic test accuracy in head-to-head studies. Gastrointest Endosc. 2017;86:986–93.PubMedCrossRef

155.

Liu CL, Lo CM, Chan JK, et al. Detection of choledocholithiasis by EUS in acute pancreatitis: a prospective evaluation in 100 consecutive patients. Gastrointest Endosc. 2001;54:325–30.PubMedCrossRef

156.

Liu CL, Fan ST, Lo CM, et al. Comparison of early endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the management of acute biliary pancreatitis: a prospective randomized study. Clin Gastroenterol Hepatol. 2005;3:1238–44.PubMedCrossRef

157.

Petrov MS, Savides TJ. Systematic review of endoscopic ultrasonography versus endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis. Br J Surg. 2009;96:967–74.PubMedCrossRef

158.

Tokumura H. Development of primary bile duct stones-function of the major papilla and biliary infection. Naika. 2005;95:217–22 (in Japanese).

159.

Hasegawa H, Sakamoto E, Komatsu S, et al. Laparoscopic management of common bile duct stones. Journal of Japan Biliary Association. 2010;24:554–560 (in Japanese with English abstract).

160.

Ministry of Health, Labour, and Welfare. A guide to the treatment of intrahepatic stone disease. Research Group for Intractable Hepatobiliary Diseases, editor. Tokyo: Bunkodo; 2011 (in Japanese).

161.

Mori T, Suzuki Y, Tazuma S, et al. Hepatolithiasis; 8th nationwide cross-sectional survey. Report of the research group on intractable hepato-biliary diseases. 2019:75–80 (in Japanese).

162.

Tsuchiya S, Tsuyuguchi T, Sakai Y, et al. Lon-term follow-up of silent stones in the peripheral bile duct. Tan to Sui. 2007;28:505–8 (in Japanese).

163.

Kudo M, Izumi N, Kubo S, et al. Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2020;50:15–46.PubMedPubMedCentralCrossRef

164.

Sasanuma H, Sata N, Endo K, et al. Profile of intrahepatic cholangiocarcinoma associated hepatolithiasis. J Jpn Biliary Assoc. 2014;28:741–746 (in Japanese with English abstract).

165.

Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:96–100.PubMedCrossRef

166.

Catena F, Ansaloni L, Bianchi E, et al. The ACTIVE (Acute Cholecystitis Trial Invasive Versus Endoscopic) Study: multicenter randomized, double-blind, controlled trial of laparoscopic versus open surgery for acute cholecystitis. Hepatogastroenterology. 2013;60:1552–6.PubMed

167.

Boo YJ, Kim WB, Kim J, et al. Systemic immune response after open versus laparoscopic cholecystectomy in acute cholecystitis: a prospective randomized study. Scand J Clin Lab Invest. 2007;67:207–14.PubMedCrossRef

168.

Johansson M, Thune A, Nelvin L, et al. Randomized clinical trial of open versus laparoscopic cholecystectomy in the treatment of acute cholecystitis. Br J Surg. 2005;92:44–9.PubMedCrossRef

169.

Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:3–16.PubMedCrossRef

170.

Kim EY, Yoon YC, Choi HJ, et al. Is there a real role of postoperative antibiotic administration for mildmoderate acute cholecystitis? A prospective randomized controlled trial. J Hepatobiliary Pancreat Sci. 2017;24:550–8.PubMedCrossRef

171.

Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.PubMedCrossRef

172.

Sakamoto T, Fujiogi M, Matsui H, et al. Timing of cholecystectomy after percutaneous transhepatic gallbladder drainage for acute cholecystitis: a nationwide inpatient database study. HPB (Oxf). 2020;22:920–6.CrossRef

173.

Siddiqui A, Kunda R, Tyberg A, et al. Three-way comparative study of endoscopic ultrasound-guided transmural gallbladder drainage using lumen-apposing metal stents versus endoscopic transpapillary drainage versus percutaneous cholecystostomy for gallbladder drainage in high-risk surgical patients with acute cholecystitis: clinical outcomes and success in an International, Multicenter Study. Surg Endosc. 2019;33:1260–70.PubMedCrossRef

174.

Rothrock SG, Green SM, Gorton E. Atropine for the treatment of biliary tract pain: a double-blind, placebo-controlled trial. Ann Emerg Med. 1993;22:1324–7.PubMedCrossRef

175.

Miyoshi S. Effect of trihydroxy propiophenone on subjective symptoms (especially in bile duct diseases). Naika Hokan. 1967;14:187–91 (in Japanese).PubMed

176.

Goldman G, Kahn PJ, Alon R, et al. Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor. Dig Dis Sci. 1989;34:809–11.PubMedCrossRef

177.

Magrini M, Rivolta G, Movilia PG, et al. Successful treatment of biliary colic with intravenous ketoprofen or lysine acetylsalicylate. Curr Med Res Opin. 1985;9:454–60.PubMedCrossRef

178.

Al-Waili N, Saloom KY. The analgesic effect of intravenous tenoxicam in symptomatic treatment of biliary colic: a comparison with hyoscine N-butylbromide. Eur J Med Res. 1998;3:475–9.PubMed

179.

Akriviadis EA, Hatzigavriel M, Kapnias D, et al. Treatment of biliary colic with diclofenac: a randomized, double-blind, placebo-controlled study. Gastroenterology. 1997;113:225–31.PubMedCrossRef

180.

Venneman NG, Besselink MG, Keulemans YC, et al. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. Hepatology. 2006;43:1276–83.PubMedCrossRef

181.

May GR, Sutherland LR, Shaffer EA. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials. Aliment Pharmacol Ther. 1993;7:139–48.PubMedCrossRef

182.

Yamaguchi A, Tazuma S, Chayama K. The modality of non-surgical treatments for gallstones: factors affecting gallstone recurrence after extracorporeal shock wave lithotripsy (ESWL) and post-therapeutic symptoms. J Jpn Biliary Assoc. 2004;18:108–113 (in Japanese with English abstract).

183.

Jain D, Bhandari BS, Agrawal N, et al. Endoscopic Ultrasound-Guided Gallbladder Drainage Using a Lumen-Apposing Metal Stent for Acute Cholecystitis: A Systematic Review. Clin Endosc. 2018;51:450–62.PubMedPubMedCentralCrossRef

184.

Ransohoff DF, Gracie WA. Treatment of gallstones. Ann Intern Med. 1993;119:606–19.PubMedCrossRef

185.

Halldestam I, Enell EL, Kullman E, et al. Development of symptoms and complications in individuals with asymptomatic gallstones. Br J Surg. 2004;91:734–8.PubMedCrossRef

186.

Gurusamy KS, Davidson BR. Surgical treatment of gallstones. Gastroenterol Clin North Am. 2010;39:229–44, viii.

187.

Shoda J, Kawamoto T. Gallbladder cancer and gallstone. J Jpn Biliary Assoc. 2012;26:205–211 (in Japanese with English abstract).

188.

Fendrick AM, Gleeson SP, Cabana MD, et al. Asymptomatic gallstones revisited. Is there a role for laparoscopic cholecystectomy? Arch Fam Med. 1993;2:959–68.PubMedCrossRef

189.

Ibrahim M, Sarvepalli S, Morris-Stiff G, et al. Gallstones: watch and wait, or intervene? Cleve Clin J Med. 2018;85:323–31.PubMedCrossRef

190.

Watemberg S, Rahmani H, Avrahami R, et al. Agenesis of the gallbladder found at laparoscopy for cholecystectomy: an unpleasant surprise. Am J Gastroenterol. 1995;90:1020–1.PubMed

191.

Reuther G, Kiefer B, Tuchmann A. Cholangiography before biliary surgery: single-shot MR cholangiography versus intravenous cholangiography. Radiology. 1996;198:561–6.PubMedCrossRef

192.

Yamashita H, Chijiiwa K, Ogawa Y, et al. The internal biliary fistula–reappraisal of incidence, type, diagnosis and management of 33 consecutive cases. HPB Surg. 1997;10:143–7.PubMedPubMedCentralCrossRef

193.

Kobari M, Ise H, Suzuki N. タイトルなし. The Biliary Tract & Pancreas. 1990;11:1317–1322 (Japanese).

194.

Tanaka N, Nobori M, Harihara Y, et al. Surgical treatment of 45 cases of contracted gallbladder. J Japanese Practical Surg Soc. 1990;52:319–325 (in Japanese with English abstract).

195.

Otani K, Chijiiwa K, Ohuchida J, et al. Surgical management of gallstones and gallbladder polyps with suspect of cancer. Surgery. 2009;71:29–33 (in Japanese).

196.

Engel JM, Deitch EA, Sikkema W. Gallbladder wall thickness: sonographic accuracy and relation to disease. AJR Am J Roentgenol. 1980;134:907–9.PubMedCrossRef

197.

Iwashita Y, Hibi T, Ohyama T, et al. Delphi consensus on bile duct injuries during laparoscopic cholecystectomy: an evolutionary cul-de-sac or the birth pangs of a new technical framework? J Hepatobiliary Pancreat Sci. 2017;24:591–602.PubMedCrossRef

198.

Okamoto K, Suzuki K, Takada T, et al. Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:55–72.PubMedCrossRef

199.

NIH Consensus Conference. Gallstones and laparoscopic cholecystectomy. JAMA. 1993;269:1018–24.CrossRef

200.

Academic Committee of The Japanese Society for Endoscopic Surgery. Questionnaire Survey on Endoscopic Surgery—Report on the Results of the 14th Total Survey. J Jpn Soc Endosc Surg. 2018;23:727–890 (Japanese)

201.

Mentes BB, Akin M, Irkorucu O, et al. Gastrointestinal quality of life in patients with symptomatic or asymptomatic cholelithiasis before and after laparoscopic cholecystectomy. Surg Endosc. 2001;15:1267–72.PubMedCrossRef

202.

Wakabayashi G, Iwashita Y, Hibi T, et al. Tokyo Guidelines 2018: surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25:73–86.PubMedCrossRef

203.

Endo I, Takada T, Hwang TL, et al. Optimal treatment strategy for acute cholecystitis based on predictive factors: Japan-Taiwan multicenter cohort study. J Hepatobiliary Pancreat Sci. 2017;24:346–61.PubMedCrossRef

204.

Kiviniemi H, Makela JT, Autio R, et al. Percutaneous cholecystostomy in acute cholecystitis in high-risk patients: an analysis of 69 patients. Int Surg. 1998;83:299–302.PubMed

205.

Sugiyama M, Tokuhara M, Atomi Y. Is percutaneous cholecystostomy the optimal treatment for acute cholecystitis in the very elderly? World J Surg. 1998;22:459–63.PubMedCrossRef

206.

Akhan O, Akinci D, Ozmen MN. Percutaneous cholecystostomy. Eur J Radiol. 2002;43:229–36.PubMedCrossRef

207.

Donald JJ, Cheslyn-Curtis S, Gillams AR, et al. Percutaneous cholecystolithotomy: is gall stone recurrence inevitable? Gut. 1994;35:692–5.PubMedPubMedCentralCrossRef

208.

Hultman CS, Herbst CA, McCall JM, et al. The efficacy of percutaneous cholecystostomy in critically ill patients. Am Surg. 1996;62:263–9.PubMed

209.

Melin MM, Sarr MG, Bender CE, et al. Percutaneous cholecystostomy: a valuable technique in high-risk patients with presumed acute cholecystitis. Br J Surg. 1995;82:1274–7.PubMedCrossRef

210.

Davis CA, Landercasper J, Gundersen LH, et al. Effective use of percutaneous cholecystostomy in high-risk surgical patients: techniques, tube management, and results. Arch Surg. 1999;134:727–31 (discussion 731–2).

211.

Jang JW, Lee SS, Song TJ, et al. Endoscopic ultrasound-guided transmural and percutaneous transhepatic gallbladder drainage are comparable for acute cholecystitis. Gastroenterology. 2012;142:805–11.PubMedCrossRef

212.

Itoi T, Coelho-Prabhu N, Baron TH. Endoscopic gallbladder drainage for management of acute cholecystitis. Gastrointest Endosc. 2010;71:1038–45.PubMedCrossRef

213.

Khan MA, Atiq O, Kubiliun N, et al. Efficacy and safety of endoscopic gallbladder drainage in acute cholecystitis: Is it better than percutaneous gallbladder drainage? Gastrointest Endosc. 2017;85(76–87): e3.

214.

Mohan BP, Khan SR, Trakroo S, et al. Endoscopic ultrasound-guided gallbladder drainage, transpapillary drainage, or percutaneous drainage in high risk acute cholecystitis patients: a systematic review and comparative meta-analysis. Endoscopy. 2020;52:96–106.PubMedCrossRef

215.

Patel IJ, Davidson JC, Nikolic B, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23:727–36.PubMedCrossRef

216.

Hamada T, Yasunaga H, Nakai Y, et al. Severe bleeding after percutaneous transhepatic drainage of the biliary system: effect of antithrombotic agents–analysis of 34 606 cases from a Japanese nationwide administrative database. Radiology. 2015;274:605–13.PubMedCrossRef

217.

Kalva NR, Vanar V, Forcione D, et al. Efficacy and Safety of Lumen Apposing Self-Expandable Metal Stents for EUS Guided Cholecystostomy: A Meta-Analysis and Systematic Review. Can J Gastroenterol Hepatol. 2018;2018:7070961.PubMedPubMedCentralCrossRef

218.

Mohan BP, Asokkumar R, Shakhatreh M, et al. Adverse events with lumen-apposing metal stents in endoscopic gallbladder drainage: a systematic review and meta-analysis. Endosc Ultrasound. 2019;8:241–8.PubMedPubMedCentralCrossRef

219.

Cui Y, Liu Y, Li Z, et al. Appraisal of diagnosis and surgical approach for Mirizzi syndrome. ANZ J Surg. 2012;82:708–13.PubMedCrossRef

220.

Kulkarni SS, Hotta M, Sher L, et al. Complicated gallstone disease: diagnosis and management of Mirizzi syndrome. Surg Endosc. 2017;31:2215–22.PubMedCrossRef

221.

Gelbard R, Khor D, Inaba K, et al. Role of Laparoscopic Surgery in the Current Management of Mirizzi Syndrome. Am Surg. 2018;84:667–71.PubMedCrossRef

222.

Chen H, Siwo EA, Khu M, et al. Current trends in the management of Mirizzi Syndrome: A review of literature. Medicine (Baltimore). 2018;97: e9691.PubMedCrossRef

223.

Beltran MA. Mirizzi syndrome: history, current knowledge and proposal of a simplified classification. World J Gastroenterol. 2012;18:4639–50.PubMedPubMedCentralCrossRef

224.

Antoniou SA, Antoniou GA, Makridis C. Laparoscopic treatment of Mirizzi syndrome: a systematic review. Surg Endosc. 2010;24:33–9.PubMedCrossRef

225.

Shirah BH, Shirah HA, Albeladi KB. Mirizzi syndrome: necessity for safe approach in dealing with diagnostic and treatment challenges. Ann Hepatobiliary Pancreat Surg. 2017;21:122–30.PubMedPubMedCentralCrossRef

226.

Yuan H, Yuan T, Sun X, et al. A Minimally Invasive Strategy for Mirizzi Syndrome Type II: Combined Endoscopic With Laparoscopic Approach. Surg Laparosc Endosc Percutan Tech. 2016;26:248–52.PubMedCrossRef

227.

Mithani R, Schwesinger WH, Bingener J, et al. The Mirizzi syndrome: multidisciplinary management promotes optimal outcomes. J Gastrointest Surg. 2008;12:1022–8.PubMedCrossRef

228.

Sepe PS, Berzin TM, Sanaka S, et al. Single-operator cholangioscopy for the extraction of cystic duct stones (with video). Gastrointest Endosc. 2012;75:206–10.PubMedCrossRef

229.

Tsuyuguchi T, Sakai Y, Sugiyama H, et al. Long-term follow-up after peroral cholangioscopy-directed lithotripsy in patients with difficult bile duct stones, including Mirizzi syndrome: an analysis of risk factors predicting stone recurrence. Surg Endosc. 2011;25:2179–85.PubMedCrossRef

230.

Bhandari S, Bathini R, Sharma A, et al. Usefulness of single-operator cholangioscopy-guided laser lithotripsy in patients with Mirizzi syndrome and cystic duct stones: experience at a tertiary care center. Gastrointest Endosc. 2016;84:56–61.PubMedCrossRef

231.

Ryozawa S, Itoi T, Katanuma A, et al. Japan Gastroenterological Endoscopy Society guidelines for endoscopic sphincterotomy. Dig Endosc. 2018;30:149–73.PubMedCrossRef

232.

Itoi T, Ryozawa S, Katanuma A, et al. Japan Gastroenterological Endoscopy Society guidelines for endoscopic papillary large balloon dilation. Dig Endosc. 2018;30:293–309.PubMedCrossRef

233.

Yasuda I, Itoi T. Recent advances in endoscopic management of difficult bile duct stones. Dig Endosc. 2013;25:376–85.PubMedCrossRef

234.

Wandling MW, Hungness ES, Pavey ES, et al. Nationwide Assessment of Trends in Choledocholithiasis Management in the United States From 1998 to 2013. JAMA Surg. 2016;151:1125–30.PubMedCrossRef

235.

Ricci C, Pagano N, Taffurelli G, et al. Comparison of Efficacy and Safety of 4 Combinations of Laparoscopic and Intraoperative Techniques for Management of Gallstone Disease With Biliary Duct Calculi: A Systematic Review and Network Meta-analysis. JAMA Surg. 2018;153: e181167.PubMedPubMedCentralCrossRef

236.

Xu J, Yang C. Cholecystectomy outcomes after endoscopic sphincterotomy in patients with choledocholithiasis: a meta-analysis. BMC Gastroenterol. 2020;20:229.PubMedPubMedCentralCrossRef

237.

Bove A, Di Renzo RM, Palone G, et al. Single-stage procedure for the treatment of cholecysto-choledocolithiasis: a surgical procedures review. Ther Clin Risk Manag. 2018;14:305–12.PubMedPubMedCentralCrossRef

238.

De Palma GD. Minimally invasive treatment of cholecysto-choledocal lithiasis: The point of view of the surgical endoscopist. World J Gastrointest Surg. 2013;5:161–6.PubMedPubMedCentralCrossRef

239.

Enochsson L, Lindberg B, Swahn F, et al. Intraoperative endoscopic retrograde cholangiopancreatography (ERCP) to remove common bile duct stones during routine laparoscopic cholecystectomy does not prolong hospitalization: a 2-year experience. Surg Endosc. 2004;18:367–71.PubMedCrossRef

240.

Liverani A, Muroni M, Santi F, et al. One-step laparoscopic and endoscopic treatment of gallbladder and common bile duct stones: our experience of the last 9 years in a retrospective study. Am Surg. 2013;79:1243–7.PubMedCrossRef

241.

Lyu Y, Cheng Y, Li T, et al. Laparoscopic common bile duct exploration plus cholecystectomy versus endoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomy for cholecystocholedocholithiasis: a meta-analysis. Surg Endosc. 2019;33:3275–86.PubMedCrossRef

242.

Schreurs WH, Vles WJ, Stuifbergen WH, et al. Endoscopic management of common bile duct stones leaving the gallbladder in situ. A cohort study with long-term follow-up. Dig Surg. 2004;21:60–4 (discussion 65).

243.

Boerma D, Rauws EA, Keulemans YC, et al. Wait-and-see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile-duct stones: a randomised trial. Lancet. 2002;360:761–5.PubMedCrossRef

244.

Dasari BV, Tan CJ, Gurusamy KS, et al. Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev. 2013;2013:CD003327.

245.

Singh AN, Kilambi R. Single-stage laparoscopic common bile duct exploration and cholecystectomy versus two-stage endoscopic stone extraction followed by laparoscopic cholecystectomy for patients with gallbladder stones with common bile duct stones: systematic review and meta-analysis of randomized trials with trial sequential analysis. Surg Endosc. 2018;32:3763–76.PubMedCrossRef

246.

Bansal VK, Misra MC, Rajan K, et al. Single-stage laparoscopic common bile duct exploration and cholecystectomy versus two-stage endoscopic stone extraction followed by laparoscopic cholecystectomy for patients with concomitant gallbladder stones and common bile duct stones: a randomized controlled trial. Surg Endosc. 2014;28:875–85.PubMedCrossRef

247.

Topal B, Vromman K, Aerts R, et al. Hospital cost categories of one-stage versus two-stage management of common bile duct stones. Surg Endosc. 2010;24:413–6.PubMedCrossRef

248.

Rogers SJ, Cello JP, Horn JK, et al. Prospective randomized trial of LC+LCBDE vs ERCP/S+LC for common bile duct stone disease. Arch Surg. 2010;145:28–33.PubMedCrossRef

249.

Tokumura H, Matsumura N, Musha H, et al. Recurrence of Common bile duct stones after surgical stone removal with preservation of papillary function. Tan to Sui. 2010;31:305–8 (in Japanese).

250.

Doi S, Yasuda I, Mabuchi M, et al. Long term outcome after EST and EPBD for bile duct stones with gallbladder stones. Tan to Sui. 2014;35:1365–1369 (in Japanese)

251.

Hasegawa H, Yamamoto H, Ymamoto R, et al. Results of the laparoscopic management of common bile duct stones –Significance of preservation of sphincter function. Tan to Sui. 2014;35:1339–43 (in Japanese).

252.

Yoshikawa J, Matsumoto J. Evaluation of endoscopic sphincter of Oddi manometry in patients with biliary diseases. J Jpn Biliary Assoc. 2003;17:396–401 (in Japanese with English abstract)

253.

Naito T, Hata T, Iseki M, et al. Manometric study of the bile duct. Tan to Sui. 2019;40:203–6 (in Japanese).

254.

Aoki Y, Tanimura H, Kawashima H, et al. Cholescintigraphic observation of the sphincter of Oddi motor activity in patients with gallstone. Nihon Geka Hokan. 1989;58:289–98.PubMed

255.

Takehara Y. Assessment of sphincter of Oddi dysfunction with pharmaco-dynamic (functional) MRCP. Tan to Sui. 2008;29:813–22 (in Japanese).

256.

Grubnik VV, Tkachenko AI, Ilyashenko VV, et al. Laparoscopic common bile duct exploration versus open surgery: comparative prospective randomized trial. Surg Endosc. 2012;26:2165–71.PubMedCrossRef

257.

Wang X, Dai C, Jiang Z, et al. Endoscopic retrograde cholangiopancreatography versus laparoscopic exploration for common bile duct stones in post-cholecystectomy patients: a retrospective study. Oncotarget. 2017;8:82114–22.PubMedPubMedCentralCrossRef

258.

Johnson AG, Hosking SW. Appraisal of the management of bile duct stones. Br J Surg. 1987;74:555–60.PubMedCrossRef

259.

Joyce WP, Keane R, Burke GJ, et al. Identification of bile duct stones in patients undergoing laparoscopic cholecystectomy. Br J Surg. 1991;78:1174–6.PubMedCrossRef

260.

Sarli L, Costi R, Gobbi S, et al. Asymptomatic bile duct stones: selection criteria for intravenous cholangiography and/or endoscopic retrograde cholangiography prior to laparoscopic cholecystectomy. Eur J Gastroenterol Hepatol. 2000;12:1175–80.PubMedCrossRef

261.

Horwood J, Akbar F, Davis K, et al. Prospective evaluation of a selective approach to cholangiography for suspected common bile duct stones. Ann R Coll Surg Engl. 2010;92:206–10.PubMedPubMedCentralCrossRef

262.

Kim SB, Kim KH, Kim TN. Comparison of Outcomes and Complications of Endoscopic Common Bile Duct Stone Removal Between Asymptomatic and Symptomatic Patients. Dig Dis Sci. 2016;61:1172–7.PubMedCrossRef

263.

Hakuta R, Hamada T, Nakai Y, et al. Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes. J Gastroenterol. 2020;55:78–85.PubMedCrossRef

264.

Itoi T, Tsuyuguchi T, Takada T, et al. TG13 indications and techniques for biliary drainage in acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2013;20:71–80.PubMedCrossRef

265.

Lee JK, Lee SH, Kang BK, et al. Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? A prospective, randomized trial. Gastrointest Endosc. 2010;71:105–10.PubMedCrossRef

266.

Ueki T, Otani K, Fujimura N, et al. Comparison between emergency and elective endoscopic sphincterotomy in patients with acute cholangitis due to choledocholithiasis: is emergency endoscopic sphincterotomy safe? J Gastroenterol. 2009;44:1080–8.PubMedCrossRef

267.

Eto K, Kawakami H, Haba S, et al. Single-stage endoscopic treatment for mild to moderate acute cholangitis associated with choledocholithiasis: a multicenter, non-randomized, open-label and exploratory clinical trial. J Hepatobiliary Pancreat Sci. 2015;22:825–30.PubMedCrossRef

268.

Ayub K, Imada R, Slavin J. Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitis. Cochrane Database Syst Rev. 2004;(4):CD003630. https://doi.org/10.1002/14651858.CD003630.pub2.

269.

Petrov MS, van Santvoort HC, Besselink MG, et al. Early endoscopic retrograde cholangiopancreatography versus conservative management in acute biliary pancreatitis without cholangitis: a meta-analysis of randomized trials. Ann Surg. 2008;247:250–7.PubMedCrossRef

270.

Uy MC, Daez ML, Sy PP, et al. Early ERCP in acute gallstone pancreatitis without cholangitis: a meta-analysis. JOP. 2009;10:299–305.PubMed

271.

Tse F, Yuan Y. Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitis. Cochrane Database Syst Rev. 2012;(5):CD009779.

272.

Burstow MJ, Yunus RM, Hossain MB, et al. Meta-Analysis of Early Endoscopic Retrograde Cholangiopancreatography (ERCP) +/- Endoscopic Sphincterotomy (ES) Versus Conservative Management for Gallstone Pancreatitis (GSP). Surg Laparosc Endosc Percutan Tech. 2015;25:185–203.PubMedCrossRef

273.

Ersoz G, Tekesin O, Ozutemiz AO, et al. Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract. Gastrointest Endosc. 2003;57:156–9.PubMedCrossRef

274.

Kim TH, Kim JH, Seo DW, et al. International consensus guidelines for endoscopic papillary large-balloon dilation. Gastrointest Endosc. 2016;83:37–47.PubMedCrossRef

275.

Feng Y, Zhu H, Chen X, et al. Comparison of endoscopic papillary large balloon dilation and endoscopic sphincterotomy for retrieval of choledocholithiasis: a meta-analysis of randomized controlled trials. J Gastroenterol. 2012;47:655–63.PubMedCrossRef

276.

Liu Y, Su P, Lin Y, et al. Endoscopic sphincterotomy plus balloon dilation versus endoscopic sphincterotomy for choledocholithiasis: A meta-analysis. J Gastroenterol Hepatol. 2013;28:937–45.PubMedCrossRef

277.

Yang XM, Hu B. Endoscopic sphincterotomy plus large-balloon dilation vs endoscopic sphincterotomy for choledocholithiasis: a meta-analysis. World J Gastroenterol. 2013;19:9453–60.PubMedPubMedCentralCrossRef

278.

Jin PP, Cheng JF, Liu D, et al. Endoscopic papillary large balloon dilation vs endoscopic sphincterotomy for retrieval of common bile duct stones: a meta-analysis. World J Gastroenterol. 2014;20:5548–56.PubMedPubMedCentralCrossRef

279.

Dong SQ, Singh TP, Zhao Q, et al. Sphincterotomy plus balloon dilation versus sphincterotomy alone for choledocholithiasis: a meta-analysis. Endoscopy. 2019;51:763–71.PubMedCrossRef

280.

Liu P, Lin H, Chen Y, et al. Comparison of endoscopic papillary large balloon dilation with and without a prior endoscopic sphincterotomy for the treatment of patients with large and/or multiple common bile duct stones: a systematic review and meta-analysis. Ther Clin Risk Manag. 2019;15:91–101.PubMedPubMedCentralCrossRef

281.

Kim KH, Rhu JH, Kim TN. Recurrence of bile duct stones after endoscopic papillary large balloon dilation combined with limited sphincterotomy: long-term follow-up study. Gut Liver. 2012;6:107–12.PubMedPubMedCentralCrossRef

282.

Maruta A, Iwashita T, Uemura S, et al. Comparison of late adverse events after endoscopic sphincterotomy versus endoscopic papillary large balloon dilation for common bile duct stones: A propensity score-based cohort analysis. Dig Endosc. 2018;30:493–500.PubMedCrossRef

283.

Miyoshi H, Inui K, Yamamoto S, et al. Extracorporeal Shock Wave Lithotripsy for Bile Duct Stones. Clin Gastroenterol. 2017;32:57–61 (in Japanese with English abstract)

284.

Jin Z, Wei Y, Tang X, et al. Single-operator peroral cholangioscope in treating difficult biliary stones: A systematic review and meta-analysis. Dig Endosc. 2019;31:256–69.PubMedCrossRef

285.

Yasuda I. Recent advances in endoscopic management of difficult bile duct stones. Nihon Shokakibyo Gakkai Zasshi. 2016;113:585–93 (in Japanese).PubMed

286.

Gad EH, Zakaria H, Kamel Y, et al. Surgical (Open and laparoscopic) management of large difficult CBD stones after different sessions of endoscopic failure: A retrospective cohort study. Ann Med Surg (Lond). 2019;43:52–63.PubMedCrossRef

287.

Lee JH, Kim HW, Kang DH, et al. Usefulness of percutaneous transhepatic cholangioscopic lithotomy for removal of difficult common bile duct stones. Clin Endosc. 2013;46:65–70.PubMedPubMedCentralCrossRef

288.

Jeong EJ, Kang DH, Kim DU, et al. Percutaneous transhepatic choledochoscopic lithotomy as a rescue therapy for removal of bile duct stones in Billroth II gastrectomy patients who are difficult to perform ERCP. Eur J Gastroenterol Hepatol. 2009;21:1358–62.PubMedCrossRef

289.

Thon HJ, Loffler A, Buess G, et al. Is ERCP a reasonable diagnostic method for excluding pancreatic and hepatobiliary disease in patients with a Billroth II resection? Endoscopy. 1983;15:93–5.PubMedCrossRef

290.

Forbes A, Cotton PB. ERCP and sphincterotomy after Billroth II gastrectomy. Gut. 1984;25:971–4.PubMedPubMedCentralCrossRef

291.

Osnes M, Rosseland AR, Aabakken L. Endoscopic retrograde cholangiography and endoscopic papillotomy in patients with a previous Billroth-II resection. Gut. 1986;27:1193–8.PubMedPubMedCentralCrossRef

292.

Nakahara K, Horaguchi J, Fujita N, et al. Therapeutic endoscopic retrograde cholangiopancreatography using an anterior oblique-viewing endoscope for bile duct stones in patients with prior Billroth II gastrectomy. J Gastroenterol. 2009;44:212–7.PubMedCrossRef

293.

Choi CW, Choi JS, Kang DH, et al. Endoscopic papillary large balloon dilation in Billroth II gastrectomy patients with bile duct stones. J Gastroenterol Hepatol. 2012;27:256–60.PubMedCrossRef

294.

Shimatani M, Hatanaka H, Kogure H, et al. Diagnostic and Therapeutic Endoscopic Retrograde Cholangiography Using a Short-Type Double-Balloon Endoscope in Patients With Altered Gastrointestinal Anatomy: A Multicenter Prospective Study in Japan. Am J Gastroenterol. 2016;111:1750–8.PubMedCrossRef

295.

Yane K, Katanuma A, Maguchi H, et al. Short-type single-balloon enteroscope-assisted ERCP in postsurgical altered anatomy: potential factors affecting procedural failure. Endoscopy. 2017;49:69–74.PubMed

296.

Itoi T, Ishii K, Sofuni A, et al. Long- and short-type double-balloon enteroscopy-assisted therapeutic ERCP for intact papilla in patients with a Roux-en-Y anastomosis. Surg Endosc. 2011;25:713–21.PubMedCrossRef

297.

Ishii K, Itoi T, Tonozuka R, et al. Balloon enteroscopy-assisted ERCP in patients with Roux-en-Y gastrectomy and intact papillae (with videos). Gastrointest Endosc. 2016;83(377–86): e6.

298.

De Koning M, Moreels TG. Comparison of double-balloon and single-balloon enteroscope for therapeutic endoscopic retrograde cholangiography after Roux-en-Y small bowel surgery. BMC Gastroenterol. 2016;16:98.PubMedPubMedCentralCrossRef

299.

Yamauchi H, Kida M, Okuwaki K, et al. Therapeutic peroral direct cholangioscopy using a single balloon enteroscope in patients with Roux-en-Y anastomosis (with videos). Surg Endosc. 2018;32:498–506.PubMedCrossRef

300.

Itoi T, Ishii K, Itokawa F, et al. Large balloon papillary dilation for removal of bile duct stones in patients who have undergone a billroth ii gastrectomy. Dig Endosc. 2010;22(Suppl 1):S98–102.PubMedCrossRef

301.

Kim GH, Kang DH, Song GA, et al. Endoscopic removal of bile-duct stones by using a rotatable papillotome and a large-balloon dilator in patients with a Billroth II gastrectomy (with video). Gastrointest Endosc. 2008;67:1134–8.PubMedCrossRef

302.

Itoi T, Sofuni A, Tsuchiya T, et al. Endoscopic ultrasonography-guided transhepatic antegrade stone removal in patients with surgically altered anatomy: case series and technical review (with videos). J Hepatobiliary Pancreat Sci. 2014;21:E86-93.PubMedCrossRef

303.

Iwashita T, Nakai Y, Hara K, et al. Endoscopic ultrasound-guided antegrade treatment of bile duct stone in patients with surgically altered anatomy: a multicenter retrospective cohort study. J Hepatobiliary Pancreat Sci. 2016;23:227–33.PubMedCrossRef

304.

Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25:31–40.PubMedCrossRef

305.

Sharaiha RZ, Khan MA, Kamal F, et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc. 2017;85:904–14.PubMedCrossRef

306.

Baron TH, Harewood GC. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol. 2004;99:1455–60.PubMedCrossRef

307.

Weinberg BM, Shindy W, Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. Cochrane Database Syst Rev. 2006;2006:CD004890.PubMedPubMedCentral

308.

Liu Y, Su P, Lin S, et al. Endoscopic papillary balloon dilatation versus endoscopic sphincterotomy in the treatment for choledocholithiasis: a meta-analysis. J Gastroenterol Hepatol. 2012;27:464–71.PubMedCrossRef

309.

Zhao HC, He L, Zhou DC, et al. Meta-analysis comparison of endoscopic papillary balloon dilatation and endoscopic sphincteropapillotomy. World J Gastroenterol. 2013;19:3883–91.PubMedPubMedCentralCrossRef

310.

Takahara N, Isayama H, Sasaki T, et al. Endoscopic papillary balloon dilation for bile duct stones in patients on hemodialysis. J Gastroenterol. 2012;47:918–23.PubMedCrossRef

311.

Kawabe T, Komatsu Y, Tada M, et al. Endoscopic papillary balloon dilation in cirrhotic patients: removal of common bile duct stones without sphincterotomy. Endoscopy. 1996;28:694–8.PubMedCrossRef

312.

Hung TH, Tseng CW, Chen YC, et al. Endoscopic papillary balloon dilation decreases the risk of bleeding in cirrhotic patients compared with endoscopic biliary sphincterotomy: A national population-based study. Medicine (Baltimore). 2019;98: e16529.PubMedCrossRef

313.

Choi D, Lim HK, Kim MJ, et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am J Roentgenol. 2005;184:1860–7.PubMedCrossRef

314.

Yasuda I, Fujita N, Maguchi H, et al. Long-term outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation for bile duct stones. Gastrointest Endosc. 2010;72:1185–91.PubMedCrossRef

315.

Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc. 2014;26:1–14.PubMedCrossRef

316.

Kato M, Uedo N, Hokimoto S, et al. Guidelines for Gastroenterological Endoscopy in Patients Undergoing Antithrombotic Treatment: 2017 Appendix on Anticoagulants Including Direct Oral Anticoagulants. Dig Endosc. 2018;30:433–40.PubMedCrossRef

317.

Mukai S, Itoi T, Baron TH, et al. Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018. J Hepatobiliary Pancreat Sci. 2017;24:537–49.PubMedCrossRef

318.

Slattery E, Kale V, Anwar W, et al. Role of long-term biliary stenting in choledocholithiasis. Dig Endosc. 2013;25:440–3.PubMedCrossRef

319.

Chopra KB, Peters RA, O’Toole PA, et al. Randomised study of endoscopic biliary endoprosthesis versus duct clearance for bileduct stones in high-risk patients. Lancet. 1996;348:791–3.PubMedCrossRef

320.

Akazawa Y, Ohtani M, Nosaka T, et al. Long-term prognosis after biliary stenting for common bile duct stones in high-risk elderly patients. J Dig Dis. 2018;19:626–34.PubMedCrossRef

321.

Seitz U, Bapaye A, Bohnacker S, et al. Advances in therapeutic endoscopic treatment of common bile duct stones. World J Surg. 1998;22:1133–44.PubMedCrossRef

322.

Itoi T, Wang HP. Endoscopic management of bile duct stones. Dig Endosc. 2010;22(Suppl 1):S69-75.PubMedCrossRef

323.

ASoP Committee, Maple JT, Ikenberry SO, et al. The role of endoscopy in the management of choledocholithiasis. Gastrointest Endosc. 2011;74:731–44.CrossRef

324.

Ishiwatari H, Kawakami H, Hisai H, et al. Balloon catheter versus basket catheter for endoscopic bile duct stone extraction: a multicenter randomized trial. Endoscopy. 2016;48:350–7.PubMedCrossRef

325.

Ozawa N, Yasuda I, Doi S, et al. Prospective randomized study of endoscopic biliary stone extraction using either a basket or a balloon catheter: the BasketBall study. J Gastroenterol. 2017;52:623–630.

326.

Manes G, Paspatis G, Aabakken L, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019;51:472–91.PubMedCrossRef

327.

Hammarstrom LE, Holmin T, Stridbeck H, et al. Long-term follow-up of a prospective randomized study of endoscopic versus surgical treatment of bile duct calculi in patients with gallbladder in situ. Br J Surg. 1995;82:1516–21.PubMedCrossRef

328.

Targarona EM, Ayuso RM, Bordas JM, et al. Randomised trial of endoscopic sphincterotomy with gallbladder left in situ versus open surgery for common bileduct calculi in high-risk patients. Lancet. 1996;347:926–9.PubMedCrossRef

329.

Suc B, Escat J, Cherqui D, et al. Surgery vs endoscopy as primary treatment in symptomatic patients with suspected common bile duct stones: a multicenter randomized trial. French Associations for Surgical Research. Arch Surg. 1998;133:702–8.PubMedCrossRef

330.

Lau JY, Leow CK, Fung TM, et al. Cholecystectomy or gallbladder in situ after endoscopic sphincterotomy and bile duct stone removal in Chinese patients. Gastroenterology. 2006;130:96–103.PubMedCrossRef

331.

McAlister VC, Davenport E, Renouf E. Cholecystectomy deferral in patients with endoscopic sphincterotomy. Cochrane Database Syst Rev. 2007;2007:CD006233.PubMedPubMedCentral

332.

Park BK, Seo JH, Jeon HH, et al. A nationwide population-based study of common bile duct stone recurrence after endoscopic stone removal in Korea. J Gastroenterol. 2018;53:670–8.PubMedCrossRef

333.

Cui ML, Cho JH, Kim TN. Long-term follow-up study of gallbladder in situ after endoscopic common duct stone removal in Korean patients. Surg Endosc. 2013;27:1711–6.PubMedCrossRef

334.

Suzuki Y, Mori T, Yokoyama M, et al. Effect of UDCA for bile duct stone recurrence and development of cholangiocarcinoma. KanTanSui. 2018;77:77–9 (in Japanese).

335.

Yamamoto R, Tazuma S, Kanno K, et al. Ursodeoxycholic acid after bile duct stone removal and risk factors for recurrence: a randomized trial. J Hepatobiliary Pancreat Sci. 2016;23:132–6.PubMedCrossRef

336.

Akiyama S, Imamura T, Tamura T, et al. Recurrent common bile duct stones composed of ursodeoxycholic acid: a report of four cases. Intern Med. 2014;53:2489–92.PubMedCrossRef

337.

Nakagawara H, Yamao K, Nomura S, et al. A case of common bile duct stones composed of ursodeoxycholic acid associated with hereditary spherocytosis. J Jpn Biliary Assoc. 2017;31:279–283 (in Japanese with English abstract).

338.

Lin CC, Lin PY, Ko CJ, et al. Hepatic resection for bilateral hepatolithiasis: a 20-year experience. ANZ J Surg. 2013;83:978–84.PubMedCrossRef

339.

Yang T, Lau WY, Lai EC, et al. Hepatectomy for bilateral primary hepatolithiasis: a cohort study. Ann Surg. 2010;251:84–90.PubMedCrossRef

340.

Kusano T, Isa T, Ohtsubo M, et al. Natural progression of untreated hepatolithiasis that shows no clinical signs at its initial presentation. J Clin Gastroenterol. 2001;33:114–7.PubMedCrossRef

341.

Kim KH, Sung CK, Park BG, et al. Clinical significance of intrahepatic biliary stricture in efficacy of hepatic resection for intrahepatic stones. J Hepatobiliary Pancreat Surg. 1998;5:303–8.PubMedCrossRef

342.

Adamek HE, Schneider AR, Adamek MU, et al. Treatment of difficult intrahepatic stones by using extracorporeal and intracorporeal lithotripsy techniques: 10 years’ experience in 55 patients. Scand J Gastroenterol. 1999;34:1157–61.PubMedCrossRef

343.

Hochberger J, Tex S, Maiss J, et al. Management of difficult common bile duct stones. Gastrointest Endosc Clin N Am. 2003;13:623–34.PubMedCrossRef

344.

Amplatz S, Piazzi L, Felder M, et al. Extracorporeal shock wave lithotripsy for clearance of refractory bile duct stones. Dig Liver Dis. 2007;39:267–72.PubMedCrossRef

345.

Ellis RD, Jenkins AP, Thompson RP, et al. Clearance of refractory bile duct stones with extracorporeal shockwave lithotripsy. Gut. 2000;47:728–31.PubMedPubMedCentralCrossRef

346.

Muratori R, Brambati M, Rossi A, et al. Extracorporeal lithotripsy of intrahepatic stones with associated strictures of intrahepatic biliary ducts. Ital J Gastroenterol Hepatol. 1998;30:624–30.PubMed

347.

Kim MH, Lee SK, Min YI, et al. Extracorporeal shockwave lithotripsy of primary intrahepatic stones. Korean J Intern Med. 1992;7:25–30.PubMedPubMedCentralCrossRef

348.

Honjo M, Itoi T, Sofuni A, et al. Nonsurgical treatment for hepatolithiasis. Tan to Sui. 2013;34:1175–82 (in Japanese).

349.

Han JK, Choi BI, Park JH, et al. Percutaneous removal of retained intrahepatic stones with a pre-shaped angulated catheter: review of 96 patients. Br J Radiol. 1992;65:9–13.PubMedCrossRef

350.

Miyoshi H, Inui K, Katano Y, et al. Percutaneous transhepatic management for postoperative anastomotic segment biliary stenosis, cholangitis and intrahepatic stones. Tan to Sui. 2018;39:395–401 (in Japanese).

351.

Oh HC, Lee SK, Lee TY, et al. Analysis of percutaneous transhepatic cholangioscopy-related complications and the risk factors for those complications. Endoscopy. 2007;39:731–6.PubMedCrossRef

352.

Furuta T, Kato M, Ito T, et al. 6th report of endoscopic complications: Results of theJapan Gastroenterological Endoscopy Sociery Survey from 2008 to 2012. Gastroenterological Endoscopy. 2016;58:1466–1491 (in Japanese with English abstract).

353.

Lamberts MP, Den Oudsten BL, Gerritsen JJ, et al. Prospective multicentre cohort study of patient-reported outcomes after cholecystectomy for uncomplicated symptomatic cholecystolithiasis. Br J Surg. 2015;102:1402–9.PubMedCrossRef

354.

Wennmacker SZ, Dijkgraaf MGW, Westert GP, et al. Persistent abdominal pain after laparoscopic cholecystectomy is associated with increased healthcare consumption and sick leave. Surgery. 2018;163:661–6.PubMedCrossRef

355.

Latenstein CSS, Wennmacker SZ, de Jong JJ, et al. Etiologies of long-term postcholecystectomy symptoms: a systematic review. Gastroenterol Res Pract. 2019;2019:4278373.PubMedPubMedCentralCrossRef

356.

Sauter GH, Moussavian AC, Meyer G, et al. Bowel habits and bile acid malabsorption in the months after cholecystectomy. Am J Gastroenterol. 2002;97:1732–5.PubMedCrossRef

357.

Fort JM, Azpiroz F, Casellas F, et al. Bowel habit after cholecystectomy: physiological changes and clinical implications. Gastroenterology. 1996;111:617–22.PubMedCrossRef

358.

Arlow FL, Dekovich AA, Priest RJ, et al. Bile acid-mediated postcholecystectomy diarrhea. Arch Intern Med. 1987;147:1327–9.PubMedCrossRef

359.

Fromm H, Tunuguntla AK, Malavolti M, et al. Absence of significant role of bile acids in diarrhea of a heterogeneous group of postcholecystectomy patients. Dig Dis Sci. 1987;32:33–44.PubMedCrossRef

360.

Sciarretta G, Furno A, Mazzoni M, et al. Post-cholecystectomy diarrhea: evidence of bile acid malabsorption assessed by SeHCAT test. Am J Gastroenterol. 1992;87:1852–4.PubMed

361.

Suhr O, Danielsson A, Nyhlin H, et al. Bile acid malabsorption demonstrated by SeHCAT in chronic diarrhoea, with special reference to the impact of cholecystectomy. Scand J Gastroenterol. 1988;23:1187–94.PubMedCrossRef

362.

Porr PJ, Szantay J, Rusu M. Post-cholecystectomy syndrome and magnesium deficiency. J Am Coll Nutr. 2004;23:745S-S747.PubMedCrossRef

363.

Schreurs WH, Juttmann JR, Stuifbergen WN, et al. Management of common bile duct stones: selective endoscopic retrograde cholangiography and endoscopic sphincterotomy: short- and long-term results. Surg Endosc. 2002;16:1068–72.PubMedCrossRef

364.

Sugiyama M, Atomi Y. Risk factors predictive of late complications after endoscopic sphincterotomy for bile duct stones: long-term (more than 10 years) follow-up study. Am J Gastroenterol. 2002;97:2763–7.PubMedCrossRef

365.

Ohashi A, Ueno N, Tamada K, et al. Assessment of residual bile duct stones with use of intraductal US during endoscopic balloon sphincteroplasty: comparison with balloon cholangiography. Gastrointest Endosc. 1999;49:328–33.PubMedCrossRef

366.

Hammarstrom LE, Stridbeck H, Ihse I. Long-term follow-up after endoscopic treatment of bile duct calculi in cholecystectomized patients. World J Surg. 1996;20:272–6.PubMedCrossRef

367.

Kageoka M, Watanabe F, Maruyama Y, et al. Long-term prognosis of patients after endoscopic sphincterotomy for choledocholithiasis. Dig Endosc. 2009;21:170–5.PubMedCrossRef

368.

Tsujino T, Kawabe T, Isayama H, et al. Management of late biliary complications in patients with gallbladder stones in situ after endoscopic papillary balloon dilation. Eur J Gastroenterol Hepatol. 2009;21:376–80.PubMedCrossRef

369.

Fujimoto T, Tsuyuguchi T, Sakai Y, et al. Long-term outcome of endoscopic papillotomy for choledocholithiasis with cholecystolithiasis. Dig Endosc. 2010;22:95–100.PubMedCrossRef

370.

Kogure H, Tsujino T, Isayama H, et al. Short- and long-term outcomes of endoscopic papillary large balloon dilation with or without sphincterotomy for removal of large bile duct stones. Scand J Gastroenterol. 2014;49:121–8.PubMedCrossRef

371.

Chan HH, Lai KH, Lin CK, et al. Endoscopic papillary large balloon dilation alone without sphincterotomy for the treatment of large common bile duct stones. BMC Gastroenterol. 2011;11:69.PubMedPubMedCentralCrossRef

372.

Kim KY, Han J, Kim HG, et al. Late Complications and Stone Recurrence Rates after Bile Duct Stone Removal by Endoscopic Sphincterotomy and Large Balloon Dilation are Similar to Those after Endoscopic Sphincterotomy Alone. Clin Endosc. 2013;46:637–42.PubMedPubMedCentralCrossRef

373.

Paspatis GA, Paraskeva K, Vardas E, et al. Long-term recurrence of bile duct stones after endoscopic papillary large balloon dilation with sphincterotomy: 4-year extended follow-up of a randomized trial. Surg Endosc. 2017;31:650–5.PubMedCrossRef

374.

Jeong S, Ki SH, Lee DH, et al. Endoscopic large-balloon sphincteroplasty without preceding sphincterotomy for the removal of large bile duct stones: a preliminary study. Gastrointest Endosc. 2009;70:915–22.PubMedCrossRef

375.

Tanaka M, Takahata S, Konomi H, et al. Long-term consequence of endoscopic sphincterotomy for bile duct stones. Gastrointest Endosc. 1998;48:465–9.PubMedCrossRef

376.

Tanaka M, Ogawa Y, Naritomi G, et al. Clinical significance of endoscopic sphincterotomy compared with surgical common bile duct exploration and surgical sphincterotomy. J Jpn Surg Soc. 1992;93:1119–22 (in Japanese with English abstract).

377.

Paganini AM, Guerrieri M, Sarnari J, et al. Thirteen years’ experience with laparoscopic transcystic common bile duct exploration for stones. Effectiveness and long-term results. Surg Endosc. 2007;21:34–40.PubMedCrossRef

378.

Tokumura H, Matsumura N, Nomura R. Laparoscopic management of common bile duct stones. J Jpn Biliary Assoc. 2012;26:40–45 (in Japanese with English abstract).

379.

Uchiyama K, Onishi H, Tani M, et al. Long-term prognosis after treatment of patients with choledocholithiasis. Ann Surg. 2003;238:97–102.PubMedPubMedCentralCrossRef

380.

Natsui M, Saito Y, Abe S, et al. Long-term outcomes of endoscopic papillary balloon dilation and endoscopic sphincterotomy for bile duct stones. Dig Endosc. 2013;25:313–21.PubMedCrossRef

381.

Ohya T, Tazuma S, Kanno K, et al. A nation-wide survey of hepatolithiasis. J Jpn Biliary Assoc. 2013;27:788–794 (in Japanese with English abstract)

382.

Yoon YS, Han HS, Shin SH, et al. Laparoscopic treatment for intrahepatic duct stones in the era of laparoscopy: laparoscopic intrahepatic duct exploration and laparoscopic hepatectomy. Ann Surg. 2009;249:286–91.PubMedCrossRef

383.

Lai EC, Ngai TC, Yang GP, et al. Laparoscopic approach of surgical treatment for primary hepatolithiasis: a cohort study. Am J Surg. 2010;199:716–21.PubMedCrossRef

384.

Tu JF, Jiang FZ, Zhu HL, et al. Laparoscopic vs open left hepatectomy for hepatolithiasis. World J Gastroenterol. 2010;16:2818–23.PubMedPubMedCentralCrossRef

385.

Ministry Of Health, Labour and Welfare. Research and Study on Refractory Liver and Biliary Diseases Tokyo: Bunkodo; 2011;32–59 (in Japanese).

386.

Li EL, Yuan RF, Liao WJ, et al. Intrahepatic bile duct exploration lithotomy is a useful adjunctive hepatectomy method for bilateral primary hepatolithiasis: an eight-year experience at a single centre. BMC Surg. 2019;19:16.PubMedPubMedCentralCrossRef

387.

Uchiyama K, Kawai M, Ueno M, et al. Reducing residual and recurrent stones by hepatectomy for hepatolithiasis. J Gastrointest Surg. 2007;11:626–30.PubMedCrossRef

388.

Otani K, Shimizu S, Chijiiwa K, et al. Comparison of treatments for hepatolithiasis: hepatic resection versus cholangioscopic lithotomy. J Am Coll Surg. 1999;189:177–82.PubMedCrossRef

Title: Evidence-based clinical practice guidelines for cholelithiasis 2021
Authors: Naotaka Fujita
Ichiro Yasuda
Itaru Endo
Hiroyuki Isayama
Takuji Iwashita
Toshiharu Ueki
Kenichiro Uemura
Akiko Umezawa
Akio Katanuma
Yu Katayose
Yutaka Suzuki
Junichi Shoda
Toshio Tsuyuguchi
Toshifumi Wakai
Kazuo Inui
Michiaki Unno
Yoshifumi Takeyama
Takao Itoi
Kazuhiko Koike
Satoshi Mochida
Publication date: 15-07-2023
Publisher: Springer Nature Singapore
Keywords: Cholecystectomy
Cholelithiasis
Cholangitis
Gallbladder Cancer
Gallbladder Cancer
Cholecystitis
Endoscopic Retrograde Cholangiopancreatography
Published in: Journal of Gastroenterology / Issue 9/2023
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI: https://doi.org/10.1007/s00535-023-02014-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2023

Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects in a population-based gastric cancer screening program

Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma

Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization

Risk of pneumonia associated with proton pump inhibitor use

Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis

Preoperative mechanical bowel preparation using conventional versus hyperosmolar polyethylene glycol-electrolyte lavage solution before laparoscopic resection for colorectal cancer (TLUMP test): a phase III, multicenter randomized controlled non-inferiority trial

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage